By Nicholas G. Miller
Milestone Pharmaceuticals shares fell after the company reported first-quarter results that missed analysts' expectations.
Shares fell 11% to $1.70 in Wednesday's premarket trading.
The company posted a loss of $26.1 million, or 20 cents a share. Analysts polled by FactSet expected a profit of 19 cents a share.
Milestone reported quarterly revenue of $238,000. Wall Street was expecting $30.1 million.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
May 13, 2026 09:08 ET (13:08 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.